Golodirsen Rebuffed and DTC Ad Lawsuit Revamped

Citeline Podcasts

English - August 22, 2019 20:59 - 18 minutes - 12.6 MB - ★★★★★ - 24 ratings
Business News Business News Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed

Previous Episode: Pink Sheet Pharma Regulatory Podcast: Zolgensma Data Manipulation, ICER's Assessment of DMD Drugs

Next Episode: Device Week, 30 August 2019: Desperately Seeking Quality Assurance Professionals

Pink Sheet reporters discuss the complete response letter for Sarepta's Duchenne muscular dystrophy drug golodirsen, the Trump administration's appeal of the DTC list price court ruling and the new Business Roundtable statement of purpose.